Abstract LB363: Discovery and characterization of TXN-A: A first-in-class, orally bioavailable ULK1 degrader with high selectivity and potency for TNBC treatment
Year: 2026
Type: conference-abstract
Source: Cancer Research
Authors: Yo Han Hong, Jung-eun Park, Jiah Lim, Yong-Chang Kim, Jun Young Choi, Ye Jin Kim, Young Hoon Choi, Hye Jung Park, Hee Jin Jeong, Chang Won Min, Eunmyong Lee, Hong Jun Kang, Hyouk Woo Lee, Sungjoon Kim, Chan Sun Park
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W7154754526
Cites:
Cited by:
Related to: